Literature DB >> 22633147

CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.

A E Rojas-López1, G Soldevila, S Meza-Pérez, G Dupont, P Ostoa-Saloma, M A Wurbel, J Ventura-Juárez, L Flores-Romo, E A García-Zepeda.   

Abstract

Analysis of the mechanisms underlying the inflammatory response in amoebiasis is important to understand the immunopathology of the disease. Mucosal associated effector and regulatory T cells may play a role in regulating the inflammatory immune response associated to Entamoeba histolytica infection in the colon. A subpopulation of regulatory T cells has recently been identified and is characterized by the expression of the chemokine receptor CCR9. In this report, we used CCR9 deficient (CCR9(-/-)) mice to investigate the role of the CCR9(+) T cells in a murine model of E. histolytica intestinal infection. Intracecal infection of CCR9(+/+), CCR9(+/-) and CCR9(-/-) mice with E. histolytica trophozoites, revealed striking differences in the development and nature of the intestinal inflammatory response observed between these strains. While CCR9(+/+) and CCR9(+/-) mice were resistant to the infection and resolved the pathogen-induced inflammatory response, CCR9(-/-) mice developed a chronic inflammatory response, which was associated with over-expression of the cytokines IFN-γ, TNF-α, IL-4, IL-6 and IL-17, while IL-10 was not present. In addition, increased levels of CCL11, CCL20 and CCL28 chemokines were detected by qRT-PCR in CCR9(-/-) mice. E. histolytica trophozoites were identified in the lumen of the cecum of CCR9(-/-) mice at seven days post infection (pi), whereas in CCR9(+/+) mice trophozoites disappeared by day 1 pi. Interestingly, the inflammation observed in CCR9(-/-) mice, was associated with a delayed recruitment of CD4(+)CD25(+)FoxP3(+) T cells to the cecal epithelium and lamina propria, suggesting that this population may play a role in the early regulation of the inflammatory response against E. histolytica, likely through IL-10 production. In support of these data, CCR9(+) T cells were also identified in colon tissue sections obtained from patients with amoebic colitis. Our data suggest that a population of CCR9(+)CD4(+)CD25(+)FoxP3(+) T cells may participate in the control and resolution of the inflammatory immune response to E. histolytica infection.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22633147     DOI: 10.1016/j.imbio.2012.04.005

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  5 in total

Review 1.  T-cell trafficking and anti-adhesion strategies in inflammatory bowel disease: current and future prospects.

Authors:  Mahmoud H Mosli; Jesus Rivera-Nieves; Brian G Feagan
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

2.  Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica.

Authors:  Nicole M Mackey-Lawrence; Xiaoti Guo; Daniel E Sturdevant; Kimmo Virtaneva; Matthew M Hernandez; Eric Houpt; Alan Sher; Stephen F Porcella; William A Petri
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

3.  Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly.

Authors:  Christian J Lechner; Karl Komander; Jana Hegewald; Xiangsheng Huang; Richard G Gantin; Peter T Soboslay; Abram Agossou; Meba Banla; Carsten Köhler
Journal:  Immun Ageing       Date:  2013-07-15       Impact factor: 6.400

4.  CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation.

Authors:  C López-Pacheco; G Soldevila; G Du Pont; R Hernández-Pando; E A García-Zepeda
Journal:  Mediators Inflamm       Date:  2016-10-04       Impact factor: 4.711

5.  A Subset of CCL25-Induced Gut-Homing T Cells Affects Intestinal Immunity to Infection and Cancer.

Authors:  Hongmei Fu; Maryam Jangani; Aleesha Parmar; Guosu Wang; David Coe; Sarah Spear; Inga Sandrock; Melania Capasso; Mark Coles; Georgina Cornish; Helena Helmby; Federica M Marelli-Berg
Journal:  Front Immunol       Date:  2019-02-25       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.